Challenges and Opportunities in the Weight Loss Drug Market

This chapter discusses the impacts of Novo Nordisk's CEO ousting on its stock and R&D amidst stiff competition in the weight loss sector. The conversation analyzes the company's future strategies and its potential to regain market dominance compared to Eli Lilly.